Global X China Biotech Innovation ETF — new fund registration

Global X Funds registered 1 new fund series on Form 485APOS, filed 2020-07-22. Featured series: Global X China Biotech Innovation ETF.

Registration

• Registrant / trust: Global X Funds
• CIK: 0001432353
• Form: 485APOS
• Filed: 2020-07-22
• Accession: 0001432353-20-000303
• Reported net assets: $2.3M

Series & classes (1)

Fees (from the effective prospectus)

• 12b-1 fee: 0.00%
• Gross expense ratio: 0.65%
• Management fee: 0.65%
• Other expenses: 0.00%

Investment objective

The Global X China Biotech Innovation ETF ("Fund") seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index ("Underlying Index").

Advisers

• GLOBAL X MANAGEMENT COMPANY LLC (Advisor)

Other filings by this registrant (15)

• 485APOS — 2026-07-27 (1 new series)
• 485APOS — 2026-07-27 (1 new series)
• 485APOS — 2026-07-13 (1 new series)
• 485APOS — 2026-07-10 (1 new series)
• 485APOS — 2026-06-26 (1 new series)
• 485APOS — 2026-06-02 (1 new series)
• 485APOS — 2026-05-22
• 485APOS — 2026-03-11 (1 new series)
• 485APOS — 2026-01-13 (1 new series)
• 485APOS — 2025-12-29 (1 new series)
• 485APOS — 2025-12-15 (1 new series)
• 485APOS — 2025-12-15

More

• Registrant profile: Global X Funds
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search